What is it about?

Distant Recurrences in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Featured Image

Read the Original

This page is a summary of: Predictive Factors for Late (>5 Years) Distant Recurrences in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer Patients: >20 Year Follow Up, Austin Journal of Clinical Case Reports, July 2017, Austin Publishing Group,
DOI: 10.26420/austinjclincaserep.2017.1119.
You can read the full text:

Read

Contributors

The following have contributed to this page